Title for MeetingAbstracts
Alphabetical listing of titles
Neutralization of CD4-independent HIV infection by anti-carbohydrate monoclonal antibodies.
Neutralization of feline immunodeficiency virus in vitro and in vivo.
Neutralization of HIV by the fraction of natural immunoglobulins obtained by ion-exchange chromatography.
Neutralization of HIV IIIB by anti-V3 antibody 694 using a PCR-based assay demonstrates an escape population undetected by conventional p24 assay.
Neutralization of HIV-1 by anti-idiotypic antibodies.
Neutralization of HIV-1 by antibody to gp120 is determined primarily by occupancy of sites on the virion irrespective of epitope specificity.
Neutralization of HIV-1 by Brazilian plasma.
Neutralization of HIV-1 by long-circulating pegylated CD4- liposomes.
Neutralization of HIV-1 by monoclonal antibodies against beta-2 microglobulin.
Neutralization of HIV-1 infection by anti-V3 loop antibody is dependent upon the host cell of the viral inoculum.
Neutralization of HIV-1 infectivity by Murine monoclonal(M) antibodies (Abs) to V3 loop correlates with protection against proteolysis.
Neutralization of HIV-1 primary isolates by polyclonal and monoclonal human antibodies.
Neutralization of in vivo HIV-1 infectivity mediated by in vitro neutralizing antibody.
Neutralization of LPS-Binding Protein (LBP) is Detrimental during Klebsiella pneumoniae Infection.
Neutralization of primary field isolates of HIV-1 from globally diverse clades.
Neutralization of primary HIV isolates post PPD-V3 loop peptide vaccine immunization in animals and in HIV+ PPD+ humans.
Neutralization of primary HIV-1 isolates by sera from primates immunized with recombinant HIV-SF2 gp120.
Neutralization of primary isolates: antibodies involved and mechanism(s) of action.
Neutralization of several HIV-1 primary isolates by sera from HIV-negative recipients of candidate HIV vaccines.
Neutralization of South African HIV-1 isolates.
Neutralization of the HIV-1 primary isolate JR-FL by human mAbs correlates with antibody binding to the oligomeric form of the envelope glycoprotein complex.
Neutralization of the MN strain of HIV-1 by monoclonal antibodies to the C4 domain of gp120.
Neutralization of the prototype and of the highly cytopathic Zairian human immunodeficiency type-1 virus (HIV-1) with sera from different geographical areas.
Neutralization on primary HIV isolates.
Neutralization profile of sera from HIV-infected patients to autologous HIV isolates and MN strain.
Neutralization profiles of various primary clinical isolates of clade B by RBCG-immunized serum antibody and Rmicron5.5 reshaping antibody.
Neutralization sensitivity and replication of SIV are modulated by truncation of gp41.
Neutralization sensitivity of HIV-1 particles is significantly decreased by interactions between virion-bound host ICAM-1 and the high-affinity form of LFA-1 on target cells.
Neutralization titers in sera from HIV-infected pregnant women, and their correlation with materno-foetal transmission.
Neutralizing and enhancing antibodies in different stages of HIV-infection.